A DTIC, DTIC-Dome, Dacarbazine CEP of the European Pharmacopoeia monograph is often referred to as a DTIC, DTIC-Dome, Dacarbazine Certificate of Suitability (COS). The purpose of a DTIC, DTIC-Dome, Dacarbazine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of DTIC, DTIC-Dome, Dacarbazine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of DTIC, DTIC-Dome, Dacarbazine to their clients by showing that a DTIC, DTIC-Dome, Dacarbazine CEP has been issued for it. The manufacturer submits a DTIC, DTIC-Dome, Dacarbazine CEP (COS) as part of the market authorization procedure, and it takes on the role of a DTIC, DTIC-Dome, Dacarbazine CEP holder for the record. Additionally, the data presented in the DTIC, DTIC-Dome, Dacarbazine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the DTIC, DTIC-Dome, Dacarbazine DMF.
A DTIC, DTIC-Dome, Dacarbazine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. DTIC, DTIC-Dome, Dacarbazine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of DTIC, DTIC-Dome, Dacarbazine suppliers with CEP (COS) on PharmaCompass.